VRDN   $20.2  2.96% Market Closed After Close 20.2 0.0

Viridian Therapeutics Inc
Total Cash 571.37M
totalCashPerShare 8.943
EBITDA -250.21M
Total Debt 22.61M
quickRatio 15.542
currentRatio 15.822
Total Revenue 288.00K
debtToEquity 4.27
Revenue/Share 0.005
ROA -0.33451
ROE -0.53965
grossProfits
freeCashflow -87.13M
operatingCashflow -168.26M
earningsGrowth
revenueGrowth 0.0
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -1002.59717
profitMargins 0.0
enterpriseValue 1.20B
forwardPE -5.8062205
floatShares 57.30M
sharesOutstanding 76.36M
sharesShort 9.79M
sharesShortPriorMonth 10.46M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.96%
Short Ratio help_outline 7.85%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 5.16
Price To Book help_outline 4.70
earningsQuarterlyGrowth
netIncomeToCommon -228.06M
trailingEps -4.43%
forwardEps -4.18%
enterpriseToEbitda -4.80
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.06 3Q 2024
institutionsCount 210
lastUpdated Nov. 7, 2024, 4:50 a.m.